Health officials across America are raising urgent warnings about a dangerous new substance called 7-OH that has flooded vape shops, petrol stations, and corner shops nationwide. This concentrated kratom byproduct delivers opioid-like effects whilst remaining legally available to purchase.

The substance, formally known as 7-hydroxymitragynine, represents what experts fear could be the next stage in the ongoing addiction crisis. Of particular concern is how 7-OH vape products and related items are specifically designed to appeal to young people through bright packaging, sweet flavours, and novelty formats.

US Food and Drug Administration Commissioner Dr Marty Makary warned: “After the last wave of the opioid epidemic, we cannot get caught flat-footed again.”

What Makes 7-OH Vape Products Dangerous

7-OH vape products contain unnaturally high concentrations of a psychoactive compound naturally found in tiny amounts in kratom plants. Manufacturers likely use synthetic chemical processes to concentrate this substance, creating products with potency comparable to or exceeding pharmaceutical opioids.

Unlike prescription medications, these 7-OH vape products face no regulation or quality control. They’re produced in unregulated laboratories and sold openly to anyone with £12-25 to spend. The ease of access combined with high potency creates an extremely dangerous combination.

Animal studies demonstrate that 7-OH binds to and activates opioid receptors in the brain, producing euphoria, sedation, and powerful pain relief. However, it also carries the same risks as other opioids: respiratory depression, physical dependence, and potentially fatal overdose.

Youth-Targeted Marketing Strategies

The marketing of 7-OH vape products appears deliberately designed to attract young consumers. Unlike traditional kratom products sold in plain brown packages with botanical imagery, these newer products use eye-catching colours, fruity flavours, and formats that resemble sweets or energy drinks.

Products are available as fruit-flavoured gummies, brightly coloured tablets, drink mixes, and even packaged to look like ice cream cones. Some brands use names that reference well-known painkillers, whilst others market themselves simply as enhanced kratom products.

This deceptive packaging means young people may unknowingly purchase highly concentrated opioid-like substances thinking they’re buying mild herbal products. The attractive presentation also increases risks of accidental consumption by children who mistake these products for sweets or treats.

Documented Health Consequences

Poison control centres have documented alarming increases in 7-OH vape product-related emergencies. Through July 2025, reported cases reached 165, with symptoms including nausea, vomiting, agitation, confusion, rapid heart rate, breathing difficulties, loss of consciousness, and seizures.

Approximately two-thirds of people exposed to 7-OH vape products alone required hospital treatment, whilst one-third experienced serious health complications. These statistics represent only reported cases – the true extent of harm likely far exceeds official figures.

Fatal overdoses involving 7-OH or related substances have increased during the same timeframe these products entered the market. The Drug Enforcement Administration’s toxicology programme has detected rising numbers of deaths linked to these substances.

Addiction Potential and Withdrawal

Medical experts emphasise that 7-OH vape products carry the same addiction potential as prescription opioids. Dr Mashal Khan, an addiction psychiatrist at Weill Cornell Medicine, explains: “Essentially the potential for dependence and withdrawal that we associate with opioids is more or less the same.”

Users report developing tolerance quickly, requiring increasing amounts to achieve the same effects. Some begin with traditional kratom products but progress to concentrated 7-OH vape products as their tolerance builds. This progression mirrors patterns seen with other addictive substances.

Withdrawal symptoms resemble those experienced with prescription opioids, including physical discomfort, cravings, and psychological distress. However, unlike regulated medications, users have no medical supervision or support when attempting to stop using these substances.

Regulatory Response and Prevention Efforts

The FDA has recommended classifying certain 7-OH vape products as controlled substances under federal drug laws. This would restrict their availability and impose criminal penalties for unauthorised distribution. The Drug Enforcement Administration is currently reviewing this recommendation.

Florida has already implemented emergency rules classifying concentrated 7-OH products as Schedule I controlled substances, making their sale, possession, or distribution illegal. Other states are considering similar measures as awareness of the danger grows.

The FDA has also issued warning letters to companies illegally marketing these products and released educational materials to help healthcare professionals and consumers understand the risks.

Impact on Communities and Families

The proliferation of 7-OH vape products represents a significant threat to community health and family wellbeing. Unlike street drugs that require connections to illegal dealers, these substances are openly sold in neighbourhood shops, making them easily accessible to curious young people.

Families report discovering these products in teenagers’ belongings, often with packaging so innocuous that parents initially mistake them for legal supplements or energy products. The legal status creates confusion about whether intervention is necessary or appropriate.

Healthcare professionals express frustration at treating patients for opioid-like addiction to substances they can legally purchase the next day. This accessibility undermines treatment efforts and creates cycles of relapse and recovery.

The Broader Prevention Challenge

The emergence of 7-OH vape products highlights ongoing challenges in protecting young people from evolving substance threats. As regulations address known dangers, manufacturers develop new products that exploit legal loopholes whilst delivering similar harmful effects.

This pattern requires constant vigilance from health officials, educators, and families. Traditional prevention messages about illegal drugs may not adequately address legally available substances that carry similar risks.

The sophisticated marketing targeting young consumers also demands updated prevention strategies that address how these products are promoted and sold. Understanding these tactics helps families and communities respond more effectively to emerging threats.

Warning Signs and Community Action

Parents and community members should be aware that 7-OH vape products often appear in bright, colourful packaging with names suggesting energy or wellness benefits. Products may be labelled as kratom, 7-OH, 7-hydroxy, or similar variations.

Warning signs of use include unexplained sedation, mood changes, small pupils, and withdrawal-like symptoms when the substance is unavailable. Young people may also display paraphernalia such as unusual tablets, liquid shots, or vape cartridges with unfamiliar branding.

Community action should focus on education about these emerging threats and advocacy for appropriate regulatory responses. Schools, healthcare providers, and law enforcement agencies need current information about new substances and their risks to respond effectively when problems arise.

Source: JAMA Network